Stroke Support Organizations

World Stroke Academy, Dylan Blacquiere, Theresa Green & Deidre Anne de Silva, 261548

The power of an SSO as change agents to improve stroke systems of care

World Stroke Academy, Mary Elizabeth Harriman, Patrice Lindsay, Jeff Sommers, Louise Helene LeBrun & Sheila Farrell, 261549

Should thrombectomy be used in mild stroke?

World Stroke Academy, Pooja Khatri & Shelagh Coutts, 259715

Post-stroke fatigue and physical inactivity

World Stroke Academy, Gillian Mead, 234639

Should thrombectomy be used in mild stroke? - CON

World Stroke Academy, Shelagh Coutts, 234104

Should thrombectomy be used in mild stroke? - PRO

World Stroke Academy, Pooja Khatri, 234103

IMAGING OF ACUTE INTRACEREBRAL HAEMORRHAGE - WHEN TO GO BEYOND CT/CTA

World Stroke Academy, Chitra Venkatasubramanian, 234097

IMAGING AFTER THROMBECTOMY: WHAT, WHEN, WHY?

World Stroke Academy, Bruce Campbell, 234096

CORE, CLOTS, COLLATERALS: BASICS AND ADVANCED METHODS

World Stroke Academy, Andrew Demchuk, 234090

Establishing acute stroke care pathways in resource poor systems of health care

World Stroke Academy, Vasantha Padma, 234073

Part 5: How to do health services research in stroke: A focus on performance measurement and quality improvement

World Stroke Academy, Dominique A Cadilhac, 228086

Post stroke fatigue: Low recognition, high impact

World Stroke Academy, M. Patrice Lindsay, 233816

Part 4: Design and implementation of observational studies to measure disease burden with a focus on stroke

World Stroke Academy, George Howard, 228085

Part 3: How to do a systematic review

World Stroke Academy, Alex Pollock, 228082

Part 2: Clinical stroke research in resource limited settings - tips and hints

World Stroke Academy, Jeyaraj Pandian and Richard Lindley, 228079

How to do good quality clinical research

World Stroke Academy, Peter Sandercock, 228078

When should robotics be used in stroke patients?

World Stroke Academy, Andreas Mayr, 226291

How to recognise a patient suitable for hemicraniectomy?

World Stroke Academy, Eric Juettler, 226639

What are the most important outcomes of motor rehabilitation after stroke?

World Stroke Academy, Jan Mehrholz, 219714

Post-Stroke Dysphagia

World Stroke Academy, Michaela Trapl-Grundschober, 219420

Post-Stroke Dysphagia Chapters

World Stroke Academy, Michaela Trapl-Grundschober, 219421

Mechanical Thrombectomy

World Stroke Academy, Prof. Diederik Dippel & Dr. Bart Emmer, 210952

Mobile stroke units

World Stroke Academy, Stephen Davis, Geoffrey Donnan, Silke Walter, 208056

How to recognise body neglect in a stroke patient?

World Stroke Academy, Thomas Benke, 204328

What are the main benefits and side effects of New Oral Anticoagulants?

World Stroke Academy, Hans Christoph Diener, 203945

What are the most frequent Posterior Circulation Syndromes?

World Stroke Academy, Patrik Michel, 203897

How to recognise stroke mimics in the acute setting

World Stroke Academy, Patrik Michel, 203694

Intravenous thrombolysis in acute stroke

World Stroke Academy, Ana Catarina Fonseca & Daniel Strbian, 203691

Case studies

World Stroke Academy, Ana Catarina Gaspar Fonseca, 203692

Intravenous thrombolysis in acute stroke

World Stroke Academy, Course Faculty, 203693

Organización de las redes asistenciales de Ataque CerebroVascular

World Stroke Academy, Sheila C. O. Martins & Daissy Liliana Mora Cuervo, 203255

Novel oral anticoagulant management issues for the stroke clinician

World Stroke Academy, Ken Butcher, 203112

Case studies

World Stroke Academy, Andrew Wassef & Ken Butcher, 203113

NOACs

World Stroke Academy, Course Faculty, 203114

Epidemiología del Ataque Cerebrovascular: Panorama Latinoamericano

World Stroke Academy, Pablo Lavados, 198864

Protocolo de atención del Ataque Cerebrovascular Agudo y Unidad de ACV agudo

World Stroke Academy, Sheila Martins, 198959

Managing a stroke unit in a rural African setting

World Stroke Academy, Alan Bryer, 193083

How to manage hypertension in the acute phase?

World Stroke Academy, Natan Bornstein, 199291

Rapid imaging. Rapid diagnosis.

World Stroke Academy, Patrik Michel, 199292

How do you consider diabetes treatment after a stroke?

World Stroke Academy, Jaakko Tuomilehto, 199293

GENERAL OR LOCAL ANESTHESIA IN INTRA ARTERIAL THERAPY (”GOLIATH”): A RANDOMIZED TRIAL

World Stroke Academy, Claus Simonsen, 183417

THE ANSTROKE TRIAL

World Stroke Academy, Pia Hendén, 183412

PRASUGREL VERSUS CLOPIDOGREL IN ISCHEMIC STROKE PATIENTS: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP TRIAL (THE PRASTRO-I)

World Stroke Academy, Kazunori Toyoda, 183419

MILD STROKE DUE TO LARGE ARTERY OCCLUSION. WHEN IS IV THROMBOLYSIS NOT ENOUGH? RESULTS FROM THE SITS-ISTR REGISTRY

World Stroke Academy, Michael Mazya, 183415

LONG-TERM ANTITHROMBOTIC TREATMENT IN INTRACRANIAL HEMORRHAGE SURVIVORS WITH ATRIAL FIBRILLATION: A SYSTEMATIC REVIEW AND META-ANALYSIS

World Stroke Academy, Eleni Korompoki, 183413

RESUMPTION OF ORAL ANTICOAGULATION AFTER INTRACEREBRAL HEMORRHAGE IS ASSOCIATED WITH DECREASED MORTALITY AND FAVORABLE FUNCTIONAL OUTCOME

World Stroke Academy, Joji Kuramatsu, 183414

Early Prolonged Ambulatory Cardiac Monitoring in Stroke (EPACS): Randomised Clinical Trial using patch-based cardiac monitoring

World Stroke Academy, James Teo, 183418

COMPARING THE IMPACT OF BASELINE COLLATERAL STATUS ASSESSED BY DIFFERENT COLLATERAL SCORES AND IMAGING MODALITIES ON OUTCOMES IN ACUTE ISCHEMIC PATIENTS: META-ANALYSIS FROM THE HERMES-COLLABORATION

World Stroke Academy, Henrik Gensicke, 183411

RISK FACTORS FOR DELIRIUM AND COGNITIVE IMPAIRMENT AFTER STROKE

World Stroke Academy, Sarah Pendlebury, 183406

ROLE OF AMYLOID IMAGING IN POST-STROKE MCI AND DEMENTIA

World Stroke Academy, Vincent CT Mok, 183405

CAA-RELATED COGNITIVE IMPAIRMENT: CLINICAL FEATURES AND MECHANISMS

World Stroke Academy, David J Werring, 183408

THE NEUROBIOLOGY OF VASCULAR DEMENTIA

World Stroke Academy, Costantino Iadecola , 183404

CHOLESTEROL: HOW LOW SHOULD WE GO, AND HOW?

World Stroke Academy, George Ntaios, 183400

ANTI-PLATELET DRUGS: WHY DO WE STILL USE ASPIRIN?

World Stroke Academy, Ale Algra, 183398

AIR POLLUTION AND RISK OF STROKE

World Stroke Academy, Valery Feigin, 183392

THE STROKE ROAD MAP

World Stroke Academy, M. Patrice Lindsay, 183393

LESSONS FROM INTERSTROKE

World Stroke Academy, Martin O’Donnell, 183395

STROKE AND POVERTY

World Stroke Academy, Bo Norrving, 183394

HOW TO ORGANIZE YOUR STROKE CENTER AND STROKE NETWORK

World Stroke Academy, Mayank Goyal, 183386

ENDOVASCULAR STROKE TREATMENT BEYOND GUIDELINES: A PLEA FOR THE PATIENT

World Stroke Academy, Jan Gralla, 183387

PRE-HOSPITAL SELECTION FOR ENDOVASCULAR TREATMENT

World Stroke Academy, Urs Fischer, 183385

ENDOVASCULAR TREATMENT OF ISCHEMIC STROKE: CURRENT EVIDENCE

World Stroke Academy, Pooja Khatri, 183388

OFF LABEL USE OF ALTEPLASE FOR ACUTE ISCHEMIC STROKE (AIS) IN PATIENTS OVER 80 YEARS OF AGE: INDIVIDUAL-PATIENT-DATA META-ANALYSIS OF EIGHT TRIALS

World Stroke Academy, Werner Hacke, 183377

TESPI(THROMBOLYSIS IN ELDERLY STROKE PATIENTS IN ITALY): RANDOMIZED CONTROLLED TRIAL OF ALTEPLASE VERSUS STANDARD TREATMENT IN PATIENTS AGED >80 YEARS WITHIN 3HRS AFTER STROKE ONSET

World Stroke Academy, Svetlana Lorenzano, 183380

PROGNOSTIC AND TREATMENT IMPACT OF PENUMBRAL IMAGING IN POOLED ANALYSIS OF RANDOMIZED TRIALS OF ENDOVASCULAR STENT THROMBECTOMY

World Stroke Academy, Bruce Campbell, 183374

TALOS: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL TO TEST THE VASCULAR AND NEUROPROTECTIVE EFFECTS OF CITALOPRAM IN PATIENTS WITH ACUTE ISCHEMIC STROKE

World Stroke Academy, Kristian Lundsgaard Kraglund, 183379

THROMBOLYSIS OR ANTICOAGULATION FOR CEREBRAL VENOUS THROMBOSIS (TO-ACT): A RANDOMISED CONTROLLED TRIAL

World Stroke Academy, Jonathan Coutinho, 183375

THE NORWEGIAN TENECTEPLASE STROKE TRIAL (NOR-TEST): RANDOMISED CONTROLLED TRIAL OF TENECTEPLASE VS. ALTEPLASE IN ACUTE ISCHAEMIC STROKE

World Stroke Academy, Nicola Logallo, 183367

CONTACT ASPIRATION VERSUS STENT RETRIEVER FRONT- LINE FOR RECANALISATION IN ACUTE CEREBRAL INFARCTION: THE ASTER TRIAL

World Stroke Academy, Bertrand Lapergue, 183365

THE T3 TRIAL: TRIAGE, TREATMENT AND TRANSFER OF PATIENTS WITH STROKE IN EMERGENCY DEPARTMENTS

World Stroke Academy, Sandy Middleton, 183369

EFFICACY OF EARLY COGNITIVE-LINGUISTIC TREATMENT FOR APHASIA DUE TO STROKE; A RANDOMISED CONTROLLED TRIAL (RATS-3)

World Stroke Academy, Femke Nouwens, 183371

DAWN in full daylight (DWI or CTP Assessment with Clinical Mismatch in the Triage of Wake Up and Late Presenting Strokes Undergoing Neurointervention)

World Stroke Academy, Raul Nogueira, 183370

PFO Closure in the Gore REDUCE Clinical Trial: Primary Results

World Stroke Academy, Scott E. Kasner, 183364

CLOSURE OF PATENT FORAMEN OVALE, ORAL ANTICOAGULANTS OR ANTIPLATELET THERAPY TO PREVENT STROKE RECURRENCE (CLOSE): A RANDOMIZED CLINICAL TRIAL

World Stroke Academy, Jean-Louis Mas, 183368

Official Welcome & Large Clinical Trials: Convenor

World Stroke Academy, Robert Mikulik, 183363

Official Welcome & Large Clinical Trials: Convenor

World Stroke Academy, Martin Dichgans, 183362

What to do when I find resistant bacteria on my ward?

World Stroke Academy, Achim Kaasch, 182302

Assessment & Evaluation

World Stroke Academy, Julian Bösel, 188672

Main neuropathological features

World Stroke Academy, Kurt Jellinger, 170314

When is multimodal imaging necessary?

World Stroke Academy, Jens Fiehler, 170247

Neurosonology and Pharmacology

World Stroke Academy, Laszlo Csiba, 166166

Management of TIA

World Stroke Academy, Peter Sandercock, 154838

Investigation of TIA

World Stroke Academy, Peter Sandercock, 154837

Clinical Assessment of TIA

World Stroke Academy, Peter Sandercock, 154836

Introduction

World Stroke Academy, Peter Sandercock, 150371

Why are TIAs important

World Stroke Academy, Peter Sandercock, 150372

TIA

World Stroke Academy, Peter Sandercock, 184709

PRO - WE SHOULD OPERATE ON MORE PATIENTS

World Stroke Academy, Girish Menon, 154555

CON - THE POLYPILL IS ENOUGH

World Stroke Academy, Jayanta Roy, 154554

PRO - PREVENTION MUST BE TARGETED

World Stroke Academy, Hans Christoph Diener, 154553

USING GENETICS TO PREDICT STROKE RISK: IS IT USEFUL NOW AND WILL IT BE IN THE FUTURE?

World Stroke Academy, Sudha Seshadri, 154552

IS GENETICS IMPORTANT FOR STROKE IN AFRICA?

World Stroke Academy, Rufus Akinyemi, 154551

INTRACEREBRAL HAEMORRHAGE: WHAT DO RECENT GENETIC STUDIES TELL THE PRACTICING CLINICIAN?

World Stroke Academy, Sudha Seshadri, 154550

TELESTROKE IN INDIA

World Stroke Academy, Vasantha Padma, 154548

TELESTROKE IN DEVELOPING COUNTRIES

World Stroke Academy, Sombat Muengtaweepongsa, 154547

THE TELESTROKE UNIT CONCEPT: MAKING EVIDENCE BASED STROKE MANAGEMENT AVAILABLE IN UNDERSERVED AREAS WORLDWIDE?

World Stroke Academy, Heinrich Audebert, 154546

HYPERTENSION IN STROKE IN ASIA

World Stroke Academy, Jong S. Kim, 154545

BP MANAGEMENT IN THE ACUTE STROKE

World Stroke Academy, Craig Anderson, 154544

GLOBAL BURDEN OF STROKE: HYPERTENSION AT THE CORE

World Stroke Academy, Daniel Lackland, 154543

PHARMACOLOGICAL APPROACHES OF EMOTIONAL AND BEHAVIORAL DISORDERS AFTER STROKE

World Stroke Academy, Jong S. Kim, 154542